The well-rounded development of all people requires the realization of common prosperity for all and the coordinated ...
The Global Generic Drugs Market, valued at USD 487.21 Billion in 2024, is poised to reach USD 898 Billion by 2035, advancing at a CAGR of 5.75% from 2025 to 2035. As healthcare systems worldwide push ...
Novartis today announced that the US Food and Drug Administration (FDA) has approved Itvisma® (onasemnogene abeparvovec-brve) for the treatment of children two years and older, teens, and adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback